PacBio's Eleven: Pacific Biosciences Announces Founding Technology Partners



By Kevin Davies

February 16, 2010 | Pacific Biosciences (PacBio), the next-generation sequencing company that intends to release the first version of its single molecule DNA sequencing instrument later this year, has announced a partner program featuring eleven leading technology providers. The Bay Area company believes that this program will help its future customers quickly adopt what it is calling a “third-generation” DNA sequencing solution into their research. 

PacBio’s Chairman and CEO Hugh Martin said it has been a long-standing priority to establish “an entire ecosystem of complementary solutions.”  In a statement, he said: “The overwhelming response from companies wanting to partner with us is extremely validating as we stand on the verge of introducing a breakthrough technology to redefine DNA sequencing.”

Members of the partner program, headlined by Amazon and featuring a spectrum of software, informatics, target-enrichment and sample prep providers (see below), will receive access to information and development tools, APIs, protocols, and potential co-marketing opportunities.

One segment not included in the program, at least for now, is the IT hardware/data storage community, but several members, including BioTeam, GenoLogics and Geospiza, serve as expert liaisons with the IT community. “PacBio has received immense interest from direct IT and storage providers that we will evaluate as the partner program matures,” said Edwin Hauw, PacBio’s senior product manager, software & informatics.

“We’re really excited,” said BioTeam managing partner Stan Gloss. “We think we provide a unique perspective to help PacBio integrate into existing environments and work with other systems that are already in place. I see our role as a system integrator and solutions architect, bringing together existing high-throughput sequence platforms, storage, HPC, and cloud technologies.”

Gloss added: “PacBio is trying to do something special here. This is all about building an ecosystem to support the platform.”

“Pacific Biosciences is changing the game with the real-time streaming of its sequencing data,” commented Geospiza president Rob Arnold. “This revolution is an ideal match for a cloud-based computing service and we look forward to working with PacBio to meet the informatics needs associated with this new era of DNA sequencing technology.”

CLC bio’s global head of PR and marketing, Lasse Goerlitz, said his company’s core strategy was to be an independent, cross-platform software provider, supporting all second-generation sequencers and now the emergence of 3rd generation sequencers. “We are very happy that we have been chosen as the first and presently only high-throughput sequencing data analysis software provider in Pacific Biosciences’ partner program,” he said. “We’re very excited about the prospects that single molecule real time sequencing brings.”

The full list of the eleven founding members of the PacBio program is as follows:

• Agilent Technologies – Provider of the SureSelect Target Enrichment System
• Amazon Web Services – Cloud computing, provider of the Amazon Elastic Compute Cloud (Amazon EC2) and Amazon Simple Storage Service (Amazon S3)
• BioTeam – IT/informatics consultants with expertise in high-performance and cloud computing, storage, wiki media and DNA sequencing platforms
• Caliper Life Sciences – Tools and services for drug discovery/life sciences, including the LabChip XT fractionation technology
• CLC bio – Bioinformatics and sequencing analysis solutions, including CLC Genomics Workbench and CLC Genomics Server
• Fluidigm – Microfluidics solutions, such as the Fluidigm Access Array System for targeted enrichment
• GenoLogics – Informatics solutions for life sciences, including Geneus, a next-gen sequencing LIMS and data management system
• GenomeQuest – Sequence data management (SDM), provider of the GenomeQuest SDM platform and cloud services
• Geospiza – Cloud computing solutions for genetic analysis, such as the GeneSifter Lab and Analysis products
• NuGEN Technologies – Sample preparation, provider of the Ovation whole genome amplification, whole transcriptome amplification, and RNA-Seq kits
• RainDance Technologies – Microdroplet-based solutions for single-molecule and single- cell analysis, provider of the RDT 1000 system and sequence enrichment kits
 
PacBio has announced that the commercial launch of its first sequencing instrument will take place in the second half of 2010. The company says its SMRT Sequencing System will ultimately make it possible to sequence individual genomes as part of routine medical care, but the platform will enable many other applications in agriculture, clean energy, and global health.

Ed. Note: BioTeam contributes the regular “Inside the Box” column in Bio-IT World.

Click here to login and leave a comment.  

0 Comments

Add Comment

Text Only 2000 character limit

Page 1 of 1



White Papers & Special Reports

sgi whp 2
Managing the Modern Genomics Data Flood
Sponsored by SGI

Managing and storing the perfect storm of multi-disciplined data pouring from next generation sequencers and other omics instruments is a central challenge in life sciences. Discover in this paper how the SGI ArcFiniti storage solution, optimized for unstructured genomics and life sciences data can: 

  • Reduce costs, proactively protect data integrity, and deliver the high performance I/O required for genomics data processing and analysis.  
  • Effectively manage capacities from 156TB to 1.4PB as a disk based, integrated hardware and software platform 


sgi - whp 1
Turning Genomics Data into Practical Insight
Sponsored by SGI

With worldwide sequencing capacity approaching 13 quadrillion DNA bases annually turning genomics data into knowledge is a true computational challenge. Read this paper and learn how the SGI UV coherent shared memory platform can:  

  • Speed results time while cost competitively tackling the most difficult computational problems across all omics disciplines. 
  • Push performance by scaling to extraordinary levels, up to 256 sockets (2,560 cores, 4,096 threads) per single system (one OS image). 

Provide support for up to 16TB of coherent shared memory in a single system image enabling extreme efficiency across a wide range of compute demands. 



accerlys-logo_2012_wh
New Complimentary Market Survey…
Collaborations and Communications Within Drug Discovery Research
Sponsored by Accelrys
This survey was conducted by the Cambridge Healthtech Media Group in January, 2012. It was sponsored by Accelrys related to their HEOS initiative to gather valid information around externalizing collaborative research while improving communications in the cloud. With 310 qualified industry respondents the survey findings reveal useful usage and trends patterns.  An insightful follow-on discussion and webinar related to this survey, and the HEOS by Scynexis SaaS portal is also available on the Bio-IT World website for complementary viewing.
 


Job Openings

tessella logo 
Scientific Software Engineer
Boston MA
$70,000 to $95,000
 

Tessella delivers software engineering and consulting services to leading pharmaceutical and biotech companies. We are recruiting Software Engineersto work with skilled bioinformaticians and scientists to identify business needs and recommend and develop technical solutions. Applicants require BS, MS or PhD in bioinformatics, biology or chemistry and 2+ years of software development in either: Java, C#, C++, C or VB.NET. 

Apply at http://jobs.tessella.com   

 

oxford nanopore logo 


 Early Access Collaborations Managers
Oxford Nanopore Technologies is developing a novel technology, GridIONTM for the direct, electronic analysis of DNA/RNA and other analytes.  As the system approaches the market, we are building a team of technically knowledgeable, highly motivated candidates with excellent customer service and facilitation skills to join our company as Collaboration Managers.  This is a unique opportunity to work with world-leading genomics customers throughout the early adoption phase of a new generation of DNA sequencing technology.. This is a facilitative, enabling role with responsibility for managing technology development collaborations with key customers at leading genomics institutions.  It will include long term management of the collaboration plan and milestones and associated meetings and documentation. Click here to find out more and apply   

Oxford Nanopore's GridION technology, VP, Sales and Marketing Oxford Nanopore Technologies is a fast-moving technology company that is developing a novel electronic molecular analysis technology. The technology is adaptable for the analysis of DNA/RNA, proteins, chemicals and other molecules.  It is therefore suitable for use in a variety of markets including scientific research and clinical applications.  As the technology approaches the market, Oxford Nanopore is seeking a visionary VP of sales and marketing to join the senior team.  The candidate will embrace the opportunities afforded by entering the market with a truly disruptive technology that has the potential to expand the number of users and the variety of applications in each target market.  This is a rare opportunity to influence the commercial strategy at an early phase of its commercial lifetime, in a well funded company.  Oxford Nanopore welcomes applications from candidates with a track record of high-level strategic commercial  leadership, who wish to apply a fresh approach to existing markets.  Experience in Life Sciences/DNA sequencing is central to this role, however we will consider your application if you have experience of disruptive technologies in other related industries.  We are particularly interested in candidates with strong expertise in the use of digital technologies for sales and marketing of scientific/technical products.  Click to  Apply  


 

For reprints and/or copyright permission, please contact  Tim McLucas, (781) 972-1342, tmclucas@healthtech.com .